Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: Finite treatment duration unlikely - Concepedia

Concepedia

Publication | Open Access

Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: Finite treatment duration unlikely

DOI Full Paper Access

256

Citations

30

References

2012

Year

Stéphane Chevaliez, Christophe Hézode, Stéphane Bahrami, Marion Grare, Jean–Michel Pawlotsky

Journal of Hepatology

VaccinationViral HepatitisImmunologyHepatitis BHepatitisFinite Treatment DurationMedicineHepatocellular CarcinomaNucleoside/nucleotide Analogue Therapy

References

	Year	Citations

Page 1